D-1179-2022 Class II Ongoing
FDA drug recall D-1179-2022 was initiated by Golden State Medical Supply Inc. on Mar 16, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 31,260 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 13, 2022
- Initiation Date
- Mar 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,260 bottles
Product description
Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
Code information
Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527, GS034231, Exp.: 10/2022; Lots: GS034810, Exp.: 01/2023; Lots: GS035240, GS035598, Exp.: 05/2023; Lots: GS036194, Exp.: 06/2023; Lots: GS036760, GS036981,GS037526, GS038177, GS038728, Exp.: 08/2023; Lots: GS038729, GS041108, Exp.: 09/2023; Lots: GS039412, GS039840, GS041109, Exp.: 12/2023; Lot: GS041655, Exp.: 01/2024; Lot: GS041656, Exp.: 05/2024. (NDC: 60429-185-90).
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1179-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026